Kaan Pazarkoylu’s Post

STAAR Surgical Reports Third Quarter 2024 Results LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial results for the third quarter ended September 27, 2024. Third Quarter 2024 Overview Net sales of $88.6 million, up 10% from prior year quarter ICL sales of $89.1 million, up 10% from prior year quarter Gross margin of 77.3% as compared to 79.2% year via Business Wire Health: Medical Devices News

The global Surgical Staplers Market is experiencing rapid growth, driven by increasing surgical procedures and technological advancements in the medical field. The market was valued at approximately USD 4.6 billion in 2023 and is expected to grow at a CAGR of 7.3% from 2024 to 2030. By 2030, the market is projected to reach USD 7.53 billion. More Details @ https://lnkd.in/dP3q_zka Key Players in Surgical Staplers Market are : Ethicon, Inc. Medtronic CONMED Corporation Smith+Nephew 3M B. Braun Group Intuitive Purple Surgical Holdings Limited Grena Limited Frankenman Group #SurgicalStaplersMarket #SurgicalStaplers #marketanalysis #vmrresearch

The global Surgical Staplers Market is experiencing rapid growth, driven by increasing surgical procedures and technological advancements in the medical field. The market was valued at approximately USD 4.6 billion in 2023 and is expected to grow at a CAGR of 7.3% from 2024 to 2030. By 2030, the market is projected to reach USD 7.53 billion. More Details @ https://lnkd.in/dP3q_zka Key Players in Surgical Staplers Market are : Ethicon, Inc. Medtronic CONMED Corporation Smith+Nephew 3M B. Braun Group Intuitive Purple Surgical Holdings Limited Grena Limited Frankenman Group #SurgicalStaplersMarket #SurgicalStaplers #marketanalysis #vmrresearch

𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝘁𝗼 𝗥𝗲𝗮𝗰𝗵 $149.4 𝗕𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dVqe_TbH The size of the global #medicaldevice #contractmanufacturing market in terms of revenue was estimated to be worth $78.9 billion in 2024 and is poised to reach $149.4 billion by 2029, growing at a CAGR of 11.4% from 2024 to 2029. Medical Device Manufacturing St. Jude Medical Zimmer Biomet Arthrex Applied Medical Wright Medical Avanos Medical Inari Medical Confluent Medical Technologies Argon Medical Devices, Inc. Cirtec Medical Nalu Medical, Inc. Greatbatch Medical Paragon Medical Nissha Medical Technologies Heraeus Medical Components Vention Medical ForTec Medical, Inc. Lake Region Medical Harmac Medical Products Norwood Medical Medpace STERIS ClinChoice Orthofix Insulet Corporation MicroVention-Terumo Nevro Glidewell Dental Alphatec Spine Integer Holdings Corporation Cutera, Inc. Verathon TekniPlex Sciton Biomerics AtriCure, Inc. Acumed Resonetics Azzur Group

Biopsy Devices Market worth $12.6 billion by 2028 Download PDF Brochure:-https://lnkd.in/dDUtJVkg The global biopsy devices market in terms of revenue was estimated to be worth $6.6 billion in 2023 and is poised to reach $12.6 billion by 2028, growing at a CAGR of 14.0% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Becton, Dickinson and Company Cook Medical Devicor Medical Products, Inc., Hologic, Inc.  Argon Medical Devices, Inc.  BKK B. Braun Melsungen AG Cardinal Health, Olympus Corporation  Boston Scientific FUJIFILM Holdings Corporation  INRAD, Medtronic #biopsydevices #cancerdiagnostics #medicaldevices #biopsytechnology #healthcareinnovation

Surgical Suction Instruments Market Estimated to Reach worth $503 million in 2029 To Find Out Detailed Information, Download FREE PDF Brochure@ https://lnkd.in/dCBiFDAi Growth Influencing Factors: Because minimally invasive procedures have shorter recovery times and cause less pain, more people are looking for them. To further propel market expansion, manufacturers are creating cutting-edge suction tools that maximize tissue stress, improve visibility, and improve patient outcomes. Stricter regulatory requirements for surgical suction tool approval, however, are anticipated to provide a hurdle to the market's expansion. Projected Surge in Global Revenue: The global surgical suction instruments market in terms of revenue was estimated to be worth $375 million in 2024 and is poised to reach $503 million by 2029, growing at a CAGR of 6.1% from 2024 to 2029. Leading Companies Operating Globally: Olympus Corporation Cardinal Health Stryker Medtronic B. Braun Group CONMED Corporation BD STERIS Teleflex ZEISS Medical Technology Integra LifeSciences KARL STORZ IndoSurgicals Private Limited Applied Medical Technology, Inc. (AMT) Amsino International, Inc. Surtex Instruments Bionix® DTR Medical® PAJUNK® Romsons Group NARANG MEDICAL LIMITED

#Therapeutic_Contact_Lenses Market Projected to Deliver Greater Revenues during the Forecast Period >> https://lnkd.in/gjZdHfKr #Therapeutic #lenses or bandage lenses shield the cornea from the #wear and #tear of our #eyelids on the outside.#TCLs (therapeutic contact lenses) are frequently used to treat a range of #corneal and #ocular surface problems (OSDs). AccuLens, Inc., Alcon., Bausch + Lomb, Dynasil Corporation of America, Johnson & Johnson Vision Care - VISTAKON., Medennium Inc.,SynergEyes, Inc., X-Cel Specialty Contacts, Abott Medicals Limited , CIBA Vision, Essilor Group, Hydrogel Vision Corp., Novartis, Contamac Ltd, Haohai Biological Technology, Hoya Vision Care, Seed Health, STAAR Surgical #medication  #lens #treatment 

The Global Surgical Sutures Market was valued at USD 5 billion in 2023 and is projected to reach a market size of USD 7.42 billion by the end of 2030. The market is anticipated to expand at a compound annual growth rate (CAGR) of 5.8% between 2024 and 2030. More Details @ https://lnkd.in/d-9nn-5B Key Players in Surgical Sutures Market are : Medtronic B.Braun Melsungen AG Smith+Nephew Boston Scientific CONMED Corporation Coloplast SurgiPro Inc. DemeTECH Corporation Teleflex Apollo Surgical Intuitive #SurgicalSuturesMarket #SurgicalSutures #vmrresearch #marketanalysis

Great insights here from Niall Cullen

🚀 Edwards keeps M&A streak going with JC Medical Acquisition! Edwards Lifesciences has just made a very interesting move by acquiring JC Medical, Inc. and its innovative J-Valve system. This acquisition includes all intellectual property and commercial rights related to J-Valve, a pioneering transcatheter aortic valve replacement (TAVR) system. This strategic decision continues Edwards' trend of key acquisitions in the MedTech space, including recent acquisitions of JenaValve, Endotronics and Innovalve Bio Medical. The J-Valve system comes with an FDA breakthrough device designation, showing its massive potential for treating severe native aortic regurgitation (AR) and AR-dominant mixed aortic valve disease. Known for its minimally invasive, transfemoral procedure, J-Valve eliminates the need for open-heart surgeries. This advancement could be a game-changer for those affected by these conditions, which are often underserved by current treatments in the US. With Edwards' backing, including an equity investment of $25 million in Genesis MedTech, the future looks bright for J-Valve's global impact. What do you think this means for the future of TAVR systems and heart valve treatments in general? Share your thoughts below or visit www.rinconsearchgroup.com to learn more. #MedTech #HealthcareInnovation #JValve